6.956USD+0.38%Mkt Cap: 28.16M USDP/E: —Last update: 2026-06-01
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting C…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap28.16M USD
Enterprise Value-5.55M USD
Revenue (TTM)7.44M USD
Gross Profit5.88M USD
Net Income (TTM)183.45M USD
Revenue/Share1.839 USD
Last Price6.956 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.71
PEG—
EV/EBITDA0.13
EV/Revenue-0.75
P/S3.75
P/B-0.64
EPS (TTM)-13.99
EPS (Forward)-9.73
52W Range
4.85027% of range12.60
52W High12.60 USD
52W Low4.850 USD
Profitability
Gross Margin91.37%
Oper. Margin-369.07%
EBITDA Margin0.00%
Profit Margin2848.63%
ROE-610.73%
ROA153.40%
Growth
Revenue Growth36.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.77M USD
CapEx (TTM)38.00K USD
FCF Margin—
FCF Yield—
Net Debt-67.99M USD
Net Debt/EBITDA1.55
Balance Sheet
Debt/Equity—
Current Ratio3.60
Quick Ratio3.28
Book Value/Sh-10.8240 USD
Cash/Share21.56 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 17, 2025
Analyst Consensus
Rating—
Target (Mean)43.00 USD
Target Range43.00 USD – 43.00 USD
# Analysts1
Ownership
Shares Out.4.05M
Float3.56M
Insiders2.03%
Institutions25.57%
Short Interest
Short Ratio14.7d
Short % Float2.87%
Short % Out.2.81%
Shares Short113.84K
Short (prev mo.)112.83K
Technical
SMA 507.023 (-1.0%)
SMA 2008.909 (-21.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)7.95K
Avg Vol (10d)8.39K
Technical Indicators
RSI (14)46.8
MACD-0.0323
MACD Signal-0.0399
MACD Hist.+0.0075
BB Upper7.245 USD
BB Middle6.997 USD
BB Lower6.749 USD
BB Width7.09%
ATR (14)0.1941 USD
Vol Ratio (20d)0.68x